Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

124.98 -0.14 (-0.11%)

Streaming Delayed Price Updated: 12:43 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

51 52 Next >

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 29, 2024

Via Benzinga

US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap' ↗

July 29, 2024

Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s...

Via Benzinga

Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula ↗

July 29, 2024

This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.

Via Benzinga

Topics Lawsuit

Abbott Laboratories's Options Frenzy: What You Need to Know ↗

July 26, 2024

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

July 26, 2024

Via Benzinga

Behind the Scenes of Abbott Laboratories's Latest Options Trends ↗

July 25, 2024

Via Benzinga

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised ↗

July 18, 2024

The drugmaker slightly topped profit and sales forecasts.

Via Investor's Business Daily

Is Beaten-Down Dexcom Stock a Buy on the Dip? ↗

July 29, 2024

The market may have overreacted to a disappointing earnings report.

Via The Motley Fool

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2024

Via Benzinga

Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On? ↗

July 26, 2024

Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today.

Via InvestorPlace

Better Buy: Abbott Laboratories vs. Intuitive Surgical ↗

July 26, 2024

The medical technology business has been good for both companies, but which is right for your portfolio?

Via The Motley Fool

3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years ↗

July 25, 2024

These stocks provide good yields and they don't come with much risk.

Via The Motley Fool

Topics Retirement

7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio ↗

July 24, 2024

With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks.

Via InvestorPlace

Intuitive Surgical Stock Outperforms Market: Highs on the Horizon

July 22, 2024

Intuitive Surgical is an AI stock that you can buy and hold forever. Its business is health care; it makes profits, and health care is growing

Via MarketBeat

Topics Artificial Intelligence

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? ↗

July 22, 2024

The big pharma company's top drug is losing ground, but its dividend keeps rising.

Via The Motley Fool

10 Best Dividend Growth Stocks to Buy and Hold Forever ↗

July 21, 2024

Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.

Via The Motley Fool

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review ↗

July 19, 2024

The Nasdaq tumbled amid chip woes.

Via Investor's Business Daily

Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers ↗

July 19, 2024

Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...

Via Benzinga

Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims ↗

July 19, 2024

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral" zone on Thursday.

Via Benzinga

Topics Stocks

7 Safe Stocks to Buy for Volatility Insurance ↗

July 18, 2024

Although not known for their riveting narratives, these safe stocks to buy can offer protection amid a growth-sector shakedown.

Via InvestorPlace

Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript ↗

July 18, 2024

ABT earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Why Are Abbott Laboratories Shares Trading Lower? ↗

July 18, 2024

Shares of Abbott Laboratories (NYSE: ABT) are trading lower on Thursday following the company's announcement of its second-quarter 2024 financial results.

Via Benzinga

Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views ↗

July 18, 2024

Via Benzinga

Topics Earnings

VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday? ↗

July 18, 2024

It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels...

Via Benzinga

Topics Stocks

ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024 ↗

July 18, 2024

ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth ↗

July 18, 2024

Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with $1.14 per share. Key highlights include FDA approval for two glucose...

Via Benzinga

Why This Leading Health Stock is a Buy No Matter the Market Move

July 18, 2024

Abbott's reliable dividend is more reliable than ever and is expected to continue growing at a high-single to low-double-digit CAGR.

Via MarketBeat

Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens ↗

July 18, 2024

Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.’s (NYSE:TSM) strong quarterly repo

Via Benzinga

Topics Economy

2 Dividend Stocks to Buy and Hold Forever ↗

July 18, 2024

These stocks don't appeal only to dividend seekers.

Via The Motley Fool

Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions ↗

July 18, 2024

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Neutral" zone on Wednesday.

Via Benzinga

Topics Government

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.